Catalyst Repository | Recro Pharma Inc. Common Stock

Recro Pharma Inc. Common Stock

(NASDAQ:REPH)

Description

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.

REPH Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$3.7700
Previous Close Volume
658148